Cleared Traditional

XELERIS 3.1 PROCESSING AND REVIEW WORKSTATION (K130884) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K130884 · Ge Medical Systems F.I. Haifa · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2013
Decision
14d
Days
Class 2
Risk

K130884 is an FDA 510(k) clearance for the XELERIS 3.1 PROCESSING AND REVIEW WORKSTATION. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Ge Medical Systems F.I. Haifa (Tirat Hacarmel, IL). The FDA issued a Cleared decision on April 12, 2013 after a review of 14 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Ge Medical Systems F.I. Haifa devices

Submission Details

510(k) Number K130884 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 29, 2013
Decision Date April 12, 2013
Days to Decision 14 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Regulatory Context
Review time vs. panel average
93d faster than avg
Panel avg: 107d · This submission: 14d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 800
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K130884.
ULTRAEXTEND USWS-900A V2.1 AND V3.1
K131822 · Toshiba America Medical Systems, In.C · Jul 2013
ESIE APPS SUITE
K132062 · Siemens Medical Solutions USA, Inc. · Jul 2013
4D VIEW
K131118 · Ge Healthcare · May 2013
INNOVA EPVISION 2.0, INNOVA EPVISION 2.0
K130069 · Ge Healthcare · Apr 2013
SYNGO, BREAST CARE
K123420 · Siemens Medical Solutions USA, Inc. · Feb 2013
SYNGO.VIA MI WORKFLOWS
K123577 · Siemens Medical Solutions USA, Inc. · Jan 2013